|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/502 | (2006.01) |
| A61K 31/496 | (2013.01) | ||
| A61K 31/4545 | (2006.01) | ||
| A61K 31/495 | (2013.01) | ||
| A61K 31/4985 | (2013.01) | ||
| A61K 31/47 | (2006.01) | ||
| A61K 31/506 | (2013.01) | ||
| A61K 31/675 | (2006.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61K 31/47 | (2013.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 31/502 | (2013.01) | ||
| A61K 31/4178 | (2006.01) | ||
| A61K 31/519 | (2013.01) | ||
| A61K 31/44 | (2006.01) | ||
| A61K 31/44 | (2013.01) | ||
| A61K 31/05 | (2006.01) | ||
| A61K 31/4178 | (2013.01) | ||
| A61K 31/496 | (2006.01) | ||
| A61K 31/4545 | (2013.01) | ||
| A61K 31/4985 | (2006.01) | ||
| A61K 31/4439 | (2013.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61K 31/675 | (2013.01) | ||
| A61P 25/24 | (2006.01) | ||
| A61K 31/05 | (2013.01) | ||
| A61K 31/495 | (2006.01) | ||
| A61P 25/24 | (2018.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 35/04 | (2018.01) | ||
| A61P 35/04 | (2006.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 9/00 | (2018.01) |
| (11) | Patento numeris | 3426250 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17897227.9 |
| Europos patento paraiškos padavimo data | 2017-05-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-01-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-03-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/032924 |
| Data | 2017-05-16 |
| (87) | Numeris | WO 2018/212764 |
| Data | 2018-11-22 |
| (72) |
SRINIVASAN, Sundar , US
CHOW, Christina , US
|
| (73) |
Bow River LLC ,
2012 Seadrift Drive, Corona Del Mar, California 92625,
US
|
| (54) | TREATING A PATIENT WITH A CYP3A4 SUBSTRATE DRUG CONTRAINDICATED FOR CONCOMITANT ADMINISTRATION WITH A STRONG CYP3A4 INHIBITOR |
| TREATING A PATIENT WITH A CYP3A4 SUBSTRATE DRUG CONTRAINDICATED FOR CONCOMITANT ADMINISTRATION WITH A STRONG CYP3A4 INHIBITOR |